Market Overview British industrial policy increasingly emphasizes domestic pharmaceutical manufacturing capabilities, creating favorable conditions for atorvastatin active pharmaceutical ingredient production expansion within the United Kingdom. While historically reliant on Asian and European API imports, UK pharmaceutical corridors are experiencing renewed investment in local chemical...